Showing results (131-140 of 444) with videos related to

Sort By:
Pageof 45
Respiratory Medicine|June 8, 2023
Real-world effectiveness of benralizumab in US subspecialist-treated adults with severe asthma: Findings from CHRONICLEReynold A Panettieri, Njira Lugogo, Wendy C Moore, et al.
Clinical and Translational Allergy|April 22, 2022
Normalisation of airflow limitation in asthma: Post-hoc analyses of TRIMARAN and TRIGGERAlberto Papi, Dave Singh, J Christian Virchow, et al.
Respiratory Research|June 27, 2012
Step-down from high dose fixed combination therapy in asthma patients: a randomized controlled trialAlberto Papi, Gabriele Nicolini, Nunzio Crimi, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|October 26, 2005
Endothelial cell activity in chronic obstructive pulmonary disease without severe pulmonary hypertensionGiuseppe Cella, Marina Saetta, Simonetta Baraldo, et al.
Respiratory Medicine|February 2, 2019
Impact of smoking status and concomitant medications on the effect of high-dose N-acetylcysteine on chronic obstructive pulmonary disease exacerbations: A post-hoc analysis of the PANTHEON studyAlberto Papi, Jinping Zheng, Gerard J Criner, et al.
The European Respiratory Journal|May 4, 2019
Asthma progression and mortality: the role of inhaled corticosteroidsPaul O'Byrne, Leonardo M Fabbri, Ian D Pavord, et al.
The Journal of Allergy and Clinical Immunology. in Practice|March 17, 2020
Disease Burden and Long-Term Risk of Persistent Very Poorly Controlled Asthma: TENOR IITmirah Haselkorn, Stanley J Szefler, Bradley E Chipps, et al.
International Journal of Chronic Obstructive Pulmonary Disease|December 10, 2015
The EFFECT trial: evaluating exacerbations, biomarkers, and safety outcomes with two dose levels of fluticasone propionate/formoterol in COPDAlberto Papi, Paul W Jones, Prashant S Dalvi, et al.
The Journal of Allergy and Clinical Immunology|August 12, 2017
More than a decade follow-up in patients with severe or difficult-to-treat asthma: The Epidemiology and Natural History of Asthma: Outcomes and Treatment Regimens (TENOR) IIBradley E Chipps, Tmirah Haselkorn, Brandee Paknis, et al.
The Journal of Allergy and Clinical Immunology|November 10, 2009
Recent asthma exacerbations predict future exacerbations in children with severe or difficult-to-treat asthmaTmirah Haselkorn, Robert S Zeiger, Bradley E Chipps, et al.
Pageof 45